Similar articles for PMID: 25601111

Year	Number of Results
1977	2
1979	1
1986	1
1988	1
1991	1
1992	1
1994	1
1995	2
1997	2
1998	1
1999	3
2000	1
2001	1
2002	2
2003	3
2004	2
2005	3
2006	2
2007	5
2008	3
2009	4
2010	3
2011	2
2012	5
2013	3
2014	8
2015	5
2016	5
2017	12
2018	8
2019	10
2020	7
2021	3
2022	1
2024	0

1

[Treatment of diabetic ketoacidosis using 2009 American Diabetes Association guidelines].

Olmos P, Donoso A, Arab JP, Niklitschek I, Mertens N, Arce E, Lemus R, Serrano V, Grassi B, Strodthoff K, Abbott E, Aizman A, González MV. Olmos P, et al. Rev Med Chil. 2014 Oct;142(10):1267-74. doi: 10.4067/S0034-98872014001000006. Rev Med Chil. 2014. PMID: 25601111 Free article. Spanish.

2

Impact of a hyperglycemic crises protocol.

Hara JS, Rahbar AJ, Jeffres MN, Izuora KE. Hara JS, et al. Endocr Pract. 2013 Nov-Dec;19(6):953-62. doi: 10.4158/EP13077.OR. Endocr Pract. 2013. PMID: 23807521

3

Efficacy of subcutaneous insulin lispro versus continuous intravenous regular insulin for the treatment of patients with diabetic ketoacidosis.

Umpierrez GE, Latif K, Stoever J, Cuervo R, Park L, Freire AX, E Kitabchi A. Umpierrez GE, et al. Am J Med. 2004 Sep 1;117(5):291-6. doi: 10.1016/j.amjmed.2004.05.010. Am J Med. 2004. PMID: 15336577 Clinical Trial.

4

Subcutaneous regular insulin for the treatment of diabetic ketoacidosis in children.

Cohen M, Leibovitz N, Shilo S, Zuckerman-Levin N, Shavit I, Shehadeh N. Cohen M, et al. Pediatr Diabetes. 2017 Jun;18(4):290-296. doi: 10.1111/pedi.12380. Epub 2016 Mar 23. Pediatr Diabetes. 2017. PMID: 27005007

5

Treatment of diabetic ketoacidosis with subcutaneous insulin aspart.

Umpierrez GE, Cuervo R, Karabell A, Latif K, Freire AX, Kitabchi AE. Umpierrez GE, et al. Diabetes Care. 2004 Aug;27(8):1873-8. doi: 10.2337/diacare.27.8.1873. Diabetes Care. 2004. PMID: 15277410 Clinical Trial.

6

Evaluation of the treatment of diabetic ketoacidosis in the medical intensive care unit.

Fusco N, Gonzales J, Yeung SY. Fusco N, et al. Am J Health Syst Pharm. 2015 Dec 1;72(23 Suppl 3):S177-82. doi: 10.2146/sp150028. Am J Health Syst Pharm. 2015. PMID: 26582306

7

Prevalence of hypokalemia in ED patients with diabetic ketoacidosis.

Arora S, Cheng D, Wyler B, Menchine M. Arora S, et al. Am J Emerg Med. 2012 Mar;30(3):481-4. doi: 10.1016/j.ajem.2011.01.002. Epub 2011 Feb 11. Am J Emerg Med. 2012. PMID: 21316179

8

Impact of diabetic ketoacidosis management in the medical intensive care unit after order set implementation.

Laliberte B, Yeung SYA, Gonzales JP. Laliberte B, et al. Int J Pharm Pract. 2017 Jun;25(3):238-243. doi: 10.1111/ijpp.12346. Epub 2017 Mar 24. Int J Pharm Pract. 2017. PMID: 28338247

9

Joint British Diabetes Societies guideline for the management of diabetic ketoacidosis.

Savage MW, Dhatariya KK, Kilvert A, Rayman G, Rees JA, Courtney CH, Hilton L, Dyer PH, Hamersley MS; Joint British Diabetes Societies. Savage MW, et al. Diabet Med. 2011 May;28(5):508-15. doi: 10.1111/j.1464-5491.2011.03246.x. Diabet Med. 2011. PMID: 21255074

10

Subcutaneous rapid-acting insulin analogues for diabetic ketoacidosis.

Andrade-Castellanos CA, Colunga-Lozano LE, Delgado-Figueroa N, Gonzalez-Padilla DA. Andrade-Castellanos CA, et al. Cochrane Database Syst Rev. 2016 Jan 21;2016(1):CD011281. doi: 10.1002/14651858.CD011281.pub2. Cochrane Database Syst Rev. 2016. PMID: 26798030 Free PMC article. Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

102 results

Results by year